Effect of COVID-19 Pandemic-Related Delays in Chemoembolization on the Survival of Patients with Hepatocellular Carcinoma.
Kittipitch BannangkoonKeerati HongsakulTeeravut TubtaweePhurich JanjindamaiPublished in: Canadian journal of gastroenterology & hepatology (2023)
The impact of the COVID-19 pandemic on liver cancer care resulted in significant decreases and delays in repeated TACE treatments in 2020 compared to 2019. However, treatment delays did not seem to significantly impact survival.